Ketamine + Cognitive Training for Suicidality in the Medical Setting
Brief Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Intervention / Treatment
-
Drug: Intravenous Ketamine
-
Behavioral: Cognitive training
-
Behavioral: Sham Training
Condition or Disease
- Suicide, Attempted
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Not yet recruiting |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years (Adult, Older Adult) |
| Enrollment: | 200 () |
| Funded by: | Other|NIH |
Masking |
|
Clinical Trial Dates
| Start date: | Jan 02, 2021 | |
|---|---|---|
| Primary Completion: | Jan 02, 2025 | |
| Completion Date: | Jan 02, 2026 | |
| Study First Posted: | Oct 08, 2020 | |
| Last Updated: | Oct 08, 2020 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
More Details
| NCT Number: | NCT04578938 |
|---|---|
| Other IDs: | MOD19100041-005|R01MH124983 |
| Study URL: | https://ClinicalTrials.gov/show/NCT04578938 |
Last updated: Jan 27, 2021